These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30415920)

  • 1. Risk Factors for Hemorrhagic and Cardioembolic Complications of Intracerebral Hemorrhage Associated with Anticoagulants.
    Osawa S; Shimizu T; Kano T; Shintoku R; Fujimaki H; Asakura K
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):325-329. PubMed ID: 30415920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
    Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH
    Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
    Murphy MP; Kuramatsu JB; Leasure A; Falcone GJ; Kamel H; Sansing LH; Kourkoulis C; Schwab K; Elm JJ; Gurol ME; Tran H; Greenberg SM; Viswanathan A; Anderson CD; Schwab S; Rosand J; Shi FD; Kittner SJ; Testai FD; Woo D; Langefeld CD; James ML; Koch S; Huttner HB; Biffi A; Sheth KN
    Stroke; 2018 Nov; 49(11):2652-2658. PubMed ID: 30355194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage.
    Pappas MA; Burke JF
    Vasc Med; 2020 Feb; 25(1):55-59. PubMed ID: 31928394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resumption of Direct Oral Anticoagulants in Patients with Acute Spontaneous Intracerebral Hemorrhage.
    Kato Y; Hayashi T; Suzuki K; Maruyama H; Kikkawa Y; Kurita H; Takao M
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104292. PubMed ID: 31375402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
    Balaghi-Inalou M; Parsa SA; Gachkar L; Andalib S
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):61-64. PubMed ID: 29076078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
    Kuramatsu JB; Gerner ST; Schellinger PD; Glahn J; Endres M; Sobesky J; Flechsenhar J; Neugebauer H; Jüttler E; Grau A; Palm F; Röther J; Michels P; Hamann GF; Hüwel J; Hagemann G; Barber B; Terborg C; Trostdorf F; Bäzner H; Roth A; Wöhrle J; Keller M; Schwarz M; Reimann G; Volkmann J; Müllges W; Kraft P; Classen J; Hobohm C; Horn M; Milewski A; Reichmann H; Schneider H; Schimmel E; Fink GR; Dohmen C; Stetefeld H; Witte O; Günther A; Neumann-Haefelin T; Racs AE; Nueckel M; Erbguth F; Kloska SP; Dörfler A; Köhrmann M; Schwab S; Huttner HB
    JAMA; 2015 Feb; 313(8):824-36. PubMed ID: 25710659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should HAS-BLED scoring be revised for better risk estimation in patients with intracerebral hemorrhage?
    Ince B; Benbir G; Gozubatik-Celik G
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):929-31. PubMed ID: 25017498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Miyamoto K; Aiba T; Arihiro S; Watanabe M; Kokubo Y; Ishibashi K; Hirose S; Wada M; Nakajima I; Okamura H; Noda T; Nagatsuka K; Noguchi T; Anzai T; Yasuda S; Ogawa H; Kamakura S; Shimizu W; Miyamoto Y; Toyoda K; Kusano K
    Heart Vessels; 2016 Aug; 31(8):1327-36. PubMed ID: 26276272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Acute Spontaneous Intracerebral Hemorrhage in Patients Receiving Oral Anticoagulants.
    Suda S; Aoki J; Shimoyama T; Kanamaru T; Muraga K; Suzuki K; Sakamoto Y; Kutsuna A; Nishimura T; Matsumoto N; Nito C; Nishiyama Y; Mishina M; Kimura K
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1007-1014. PubMed ID: 30612891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resumption of antithrombotic treatment after an intracerebral haemorrhage].
    Kappelle LJ; Hofmeijer J; Chamuleau SA; van Nieuwenhuizen KM; Hemels ME; Klijn CJ
    Ned Tijdschr Geneeskd; 2015; 159():A8507. PubMed ID: 25873219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Oral Anticoagulant Therapy in Medical Inpatients ≥65 Years With Atrial Fibrillation.
    Bo M; Sciarrillo I; Li Puma F; Badinella Martini M; Falcone Y; Iacovino M; Grisoglio E; Menditto E; Fonte G; Brunetti E; Maggiani G; Isaia GC; Gaita F
    Am J Cardiol; 2016 Feb; 117(4):590-595. PubMed ID: 26718230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
    Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.